Literature DB >> 21300939

Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

Matthew Large1, Swapnil Sharma, Michael T Compton, Tim Slade, Olav Nielssen.   

Abstract

CONTEXT: A number of studies have found that the use of cannabis and other psychoactive substances is associated with an earlier onset of psychotic illness.
OBJECTIVE: To establish the extent to which use of cannabis, alcohol, and other psychoactive substances affects the age at onset of psychosis by meta-analysis. DATA SOURCES: Peer-reviewed publications in English reporting age at onset of psychotic illness in substance-using and non-substance-using groups were located using searches of CINAHL, EMBASE, MEDLINE, PsycINFO, and ISI Web of Science. STUDY SELECTION: Studies in English comparing the age at onset of psychosis in cohorts of patients who use substances with age at onset of psychosis in non-substance-using patients. The searches yielded 443 articles, from which 83 studies met the inclusion criteria. DATA EXTRACTION: Information on study design, study population, and effect size were extracted independently by 2 of us. DATA SYNTHESIS: Meta-analysis found that the age at onset of psychosis for cannabis users was 2.70 years younger (standardized mean difference = -0.414) than for nonusers; for those with broadly defined substance use, the age at onset of psychosis was 2.00 years younger (standardized mean difference = -0.315) than for nonusers. Alcohol use was not associated with a significantly earlier age at onset of psychosis. Differences in the proportion of cannabis users in the substance-using group made a significant contribution to the heterogeneity in the effect sizes between studies, confirming an association between cannabis use and earlier mean age at onset of psychotic illness.
CONCLUSIONS: The results of meta-analysis provide evidence for a relationship between cannabis use and earlier onset of psychotic illness, and they support the hypothesis that cannabis use plays a causal role in the development of psychosis in some patients. The results suggest the need for renewed warnings about the potentially harmful effects of cannabis.

Entities:  

Mesh:

Year:  2011        PMID: 21300939     DOI: 10.1001/archgenpsychiatry.2011.5

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  140 in total

Review 1.  Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Authors:  Dragan M Svrakic; Patrick J Lustman; Ashok Mallya; Taylor Andrea Lynn; Rhonda Finney; Neda M Svrakic
Journal:  Mo Med       Date:  2012 Mar-Apr

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Perspective: Be clear about the real risks.

Authors:  Matthew Hill
Journal:  Nature       Date:  2015-09-24       Impact factor: 49.962

4.  Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins.

Authors:  Ragnar Nesvåg; Ted Reichborn-Kjennerud; Nathan A Gillespie; Gun Peggy Knudsen; Jørgen G Bramness; Kenneth S Kendler; Eivind Ystrom
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

Review 5.  Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.

Authors:  Marc W Manseau; Donald C Goff
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

6.  State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.

Authors:  Ryan K McBain; Eunice C Wong; Joshua Breslau; Amy L Shearer; Matthew S Cefalu; Elizabeth Roth; M Audrey Burnam; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2020-07-24       Impact factor: 4.492

7.  Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.

Authors:  Luca Pauselli; Michael L Birnbaum; Beatriz Paulina Vázquez Jaime; Enrico Paolini; Mary E Kelley; Beth Broussard; Michael T Compton
Journal:  Schizophr Res       Date:  2018-02-04       Impact factor: 4.939

Review 8.  Cannabis controversies: how genetics can inform the study of comorbidity.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Addiction       Date:  2014-01-19       Impact factor: 6.526

9.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

10.  No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use.

Authors:  Daniel Fuster; Debbie M Cheng; Donald Allensworth-Davies; Tibor P Palfai; Jeffrey H Samet; Richard Saitz
Journal:  J Gen Intern Med       Date:  2013-09-19       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.